Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Pharmacy Reports

Adjunctive corticosteroid therapy and clinical recovery in hospitalized community-acquired pneumonia patients: a retrospective comparative study Rostalina, Irma; Meiliana, Made Laksmi; Kusniawati, Mega Ayu
Pharmacy Reports Vol. 5 No. 2 (2025): Pharmacy Reports
Publisher : Indonesian Young Scientist Group and UPN Veteran Jakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51511/pr.111

Abstract

Dysregulated inflammation in community-acquired pneumonia (CAP) has prompted investigation of corticosteroids as adjunctive therapy; however, their clinical utility remains contested, particularly in non-severe presentations and resource-limited settings. This study aims to evaluate the effect of adjunctive corticosteroid therapy on length of hospital stay and key clinical parameters in adult CAP patients at a secondary referral hospital in Bandar Lampung, Indonesia. This retrospective comparative study analyzed medical records of 59 eligible CAP patients admitted during 2023. Patients were categorized into steroid (n = 39) and non-steroid (n = 20) groups. Time to clinical improvement in temperature, cough, dyspnea, and respiratory rate, as well as length of hospital stay, were compared using chi-square and Fisher's exact tests. Steroid-treated patients had significantly longer hospital stays (28.2% vs. 5.0% with stays ≥5 days; p = 0.044), slower dyspnea resolution (p = 0.022), and delayed respiratory rate normalization (p = 0.042). No significant differences were observed for temperature (p = 0.653) or cough resolution (p = 0.679). Adjunctive corticosteroid therapy was not associated with clinical benefit in this cohort and was associated with prolonged hospitalization. Severity-based patient selection and standardized protocols are essential before routine corticosteroid use can be recommended in similar settings.
Concentration-dependent antibacterial activity of Ruellia tuberosa L. leaf ethanol extract against Propionibacterium acnes ATCC 6919 Yani, Indri; Hamidu, La; Meiliana, Made Laksmi
Pharmacy Reports Vol. 5 No. 3 (2025): Pharmacy Reports
Publisher : Indonesian Young Scientist Group and UPN Veteran Jakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51511/pr.112

Abstract

Rising antibiotic resistance in Propionibacterium acnes necessitates alternative anti-acne agents. Ruellia tuberosa L. (Acanthaceae) possesses documented antibacterial potential, yet its activity against P. acnes remains unevaluated. This study investigated the concentration-dependent antibacterial activity of R. tuberosa leaf ethanol extract against P. acnes ATCC 6919. Leaves were extracted by maceration using 96% ethanol. Phytochemical classes were identified by thin-layer chromatography. Antibacterial activity was assessed using the Kirby-Bauer disc diffusion method in triplicate (n = 3) at concentrations of 15%, 20%, 25%, 30%, and 35% (w/v), with 0.1% clindamycin and distilled water as positive and negative controls, respectively. Data were analyzed by one-way ANOVA with Tukey's HSD post-hoc test. TLC confirmed alkaloids, flavonoids, tannins, saponins, and terpenoids. Inhibition zones increased from 5.00 ± 1.30 mm (15%, weak) to 11.82 ± 0.84 mm (35%, strong), compared to 22.05 ± 0.27 mm for clindamycin. Significant differences were detected among all groups (p < 0.0001). The 30% concentration was the lowest to achieve strong inhibitory activity, with no significant advantage conferred by increasing to 35%. R. tuberosa leaf ethanol extract exhibits concentration-dependent antibacterial activity against P. acnes, with 30% identified as the optimal concentration, warranting further investigation for botanical anti-acne formulation development.